Abstract:Purpose Sirtuin7 (SIRT7), as a member of the sirtuin and NAD + -dependent protein-modifying enzyme family, plays an important role in regulating cellular metabolism, stress responses, tumorigenesis, and aging. Ubiquitination and deubiquitination are reversible post-translational modifications that regulate protein stability, enzyme activity, protein–protein interactions, and cellular signaling transduction. However, whether SIRT7 is regulated by deubiquitination signaling is unclear. This study aims to elucidate the molecular mechanism of SIRT7 via deubiquitination signaling. Methods USP17L2 or SIRT7-targeting shRNAs were used to deplete USP17L2 or SIRT7. Western blot was applied to assess the effects of USP17L2 or SIRT7 depletion. A co-immunoprecipitation assay was used to detect the interaction relationship. Cell Counting Kit-8 assays were applied to assess the viability of breast cancer cells. An immunohistochemistry assay was employed to detect the protein level in samples from breast cancer patients, and the TCGA database was applied to analyze the survival rate of breast cancer patients. Statistical analyses were performed with the Student’s t test (two-tailed unpaired) and χ 2 test. Results We find that the deubiquitinase USP17L2 interacts with and deubiquitinates SIRT7, thereby increasing SIRT7 protein stability. In addition, USP17L2 regulates DNA damage repair through SIRT7. Furthermore, SIRT7 polyubiquitination is increased by knocking down of USP17L2, which leads to cancer cells sensitizing to chemotherapy. In breast cancer patient samples, high expression of USP17L2 is correlated with increased levels of SIRT7 protein. In conclusion, our study demonstrates that the USP17L2-SIRT7 axis is the new regulator in DNA damage response and chemo-response, suggesting that USP17L2 may be a prognostic factor and a potential therapeutic target in breast cancer. Conclusion Our results highlighted that USP17L2 regulates the chemoresistance of breast cancer cells in a SIRT7-dependent manner. Moreover, the role of USP17L2 as a potential therapeutic target in breast cancer and a prognostic factor for patients was elucidated.

USP7 Negatively Controls Global DNA Methylation by Attenuating Ubiquitinated Histone-Dependent DNMT1 Recruitment

Allosteric Regulation of Uhrf1 for Dna Methylation Maintenance

Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancer

Molecular Mechanism for USP7-mediated DNMT1 Stabilization by Acetylation

USP37 Regulates DNA Damage Response Through Stabilizing and Deubiquitinating BLM

USP17L2-SIRT7 axis regulates DNA damage repair and chemoresistance in breast cancer cells

M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability

Direct Readout of Heterochromatic H3K9me3 Regulates DNMT1-mediated Maintenance DNA Methylation.

SET8 Prevents Excessive DNA Methylation by Methylation-Mediated Degradation of UHRF1 and DNMT1

H3K27me3 shapes DNA methylome by inhibiting UHRF1-mediated H3 ubiquitination

USP7 facilitates SMAD3 autoregulation to repress cancer progression in p53-deficient lung cancer

An Allosteric Interaction Links USP7 to Deubiquitination and Chromatin Targeting of UHRF1

UHRF1 Targets DNMT1 for DNA Methylation Through Cooperative Binding of Hemi-Methylated DNA and Methylated H3K9.

Ubiquitin-specific Protease 7 Sustains DNA Damage Response and Promotes Cervical Carcinogenesis.

USP39 Regulates DNA Damage Response and Chemo-Radiation Resistance by Deubiquitinating and Stabilizing CHK2.

S Phase-Dependent Interaction with DNMT1 Dictates the Role of UHRF1 but Not UHRF2 in DNA Methylation Maintenance

USP7 regulates the stability and function of HLTF through deubiquitination.

PGC7 Regulates Genome-Wide DNA Methylation by Regulating ERK-Mediated Subcellular Localization of DNMT1

USP37 prevents unscheduled replisome unloading through MCM complex deubiquitination

USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities

USP7 promotes cervical cancer progression by stabilizing MTDH expression through deubiquitination